Cabaletta Bio, Inc. — Director's Dealing 2020

Feb 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2020-02-11

Reporting Person: DANIELS BRIAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-11	Stock Option (Right to Buy)	$15.42	A	44000	Acquired	2030-02-10	Common Stock (44000)	Direct

Footnotes

F1: The Shares shall vest and become exercisable in 12 equal quarterly installments commencing on October 25, 2019, provided that the Reporting Person continues to have a Service Relationship with the Company on each vesting date.